We are live on ! Find out more
CCI

Columbus Circle Investors Portfolio holdings

AUM $2.28B
1-Year Est. Return 135.57%
This Fund
S&P 500
This Quarter Est. Return
+9.4%
1 Year Est. Return
+135.57%
3 Year Est. Return
+366.4%
5 Year Est. Return
+795.38%
10 Year Est. Return
AUM
$6.05B
AUM Growth
-$1.05B
Cap. Flow
-$1.5B
Cap. Flow %
-24.75%
Top 10 Hldgs %
21.54%
Holding
334
New
64
Increased
61
Reduced
118
Closed
91

Top Buys

Rank Stock Value
1
HOLX
Hologic
HOLX
+$53M
2
FMC icon
FMC
FMC
+$48.7M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$47.1M
4
CMG icon
Chipotle Mexican Grill
CMG
+$46.7M
5
CMI icon
Cummins
CMI
+$43.5M

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$92.1M
2
WP
Worldpay, Inc.
WP
+$81.6M
3
ADI icon
Analog Devices
ADI
+$73.5M
4
MSFT icon
Microsoft
MSFT
+$69.7M
5
PG icon
Procter & Gamble
PG
+$69M

Sector Composition

Rank Sector Weight
1 Technology 23.43%
2 Consumer Discretionary 18.14%
3 Healthcare 16.2%
4 Industrials 13.58%
5 Financials 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRCL
226
DELISTED
Stericycle Inc
SRCL
$969K 0.02%
12,695
-7,645
-38% -$628K
CFMS
227
DELISTED
Conformis, Inc. Common Stock
CFMS
$957K 0.02%
8,927
+2,861
+47% +$344K
FOLD
228
DELISTED
Amicus Therapeutics
FOLD
$923K 0.02%
91,622
-68,895
-43% -$554K
AGIO icon
229
Agios Pharmaceuticals
AGIO
$1.92B
$908K 0.02%
17,640
-25,240
-59% -$1.29M
GKOS icon
230
Glaukos
GKOS
$10.4B
$895K 0.01%
+21,575
New +$929K
P
231
Everpure Inc
P
$29B
$816K 0.01%
+63,669
New +$741K
RCKT icon
232
Rocket Pharmaceuticals
RCKT
$385M
$721K 0.01%
94,929
-1,378
-1% -$10.3K
AVDL
233
DELISTED
Avadel Pharmaceuticals
AVDL
$564K 0.01%
51,137
+7,315
+17% +$73.4K
PRTK
234
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$480K 0.01%
+19,937
New +$441K
PDCO
235
DELISTED
Patterson Companies, Inc.
PDCO
$438K 0.01%
+9,323
New +$420K
BDC icon
236
Belden
BDC
$5.06B
$395K 0.01%
+5,241
New +$375K
CSIQ icon
237
Canadian Solar
CSIQ
$1.03B
$318K 0.01%
+19,959
New +$267K
COHR icon
238
Coherent
COHR
$72B
$315K 0.01%
9,173
-105,344
-92% -$3.41M
VECO icon
239
Veeco
VECO
$3.18B
$291K ﹤0.01%
10,462
-23,243
-69% -$714K
NPTN
240
DELISTED
NEOPHOTONICS CORP
NPTN
$286K ﹤0.01%
+37,052
New +$313K
OTIC
241
DELISTED
Otonomy, Inc.
OTIC
$243K ﹤0.01%
12,875
-64,688
-83% -$902K
PTCT icon
242
PTC Therapeutics
PTCT
$5.96B
$232K ﹤0.01%
12,640
-145,940
-92% -$1.97M
VEEV icon
243
Veeva Systems
VEEV
$37.3B
$230K ﹤0.01%
+3,750
New +$216K
ACRS icon
244
Aclaris Therapeutics
ACRS
$837M
-180,320
Closed -$5.38M
ADBE icon
245
Adobe
ADBE
$107B
-2,344
Closed -$305K
ADI icon
246
Analog Devices
ADI
$189B
-896,379
Closed -$73.5M
AMGN icon
247
Amgen
AMGN
$220B
-7,294
Closed -$1.2M
BC icon
248
Brunswick
BC
$5.33B
-259,547
Closed -$15.9M
BHC icon
249
Bausch Health
BHC
$2.24B
-75,252
Closed -$830K
BIIB icon
250
Biogen
BIIB
$30.3B
-149,379
Closed -$40.8M

Similar funds

Columbus Circle Investors's Q2 2017 Portfolio in Review

As of Q2 2017, Columbus Circle Investors held 334 positions worth $6.05B, down 15% from $7.11B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Columbus Circle Investors withdrew a net $1.5B in Q2 2017, closing 91 positions and reducing 118 holdings. Its most notable exit was Intuitive Surgical, an estimated $92.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Columbus Circle Investors opened a new position in Hologic worth $54.5M.

  • Columbus Circle Investors's largest Q2 2017 buy was Hologic: 1,201,219 shares worth $54.5M.
  • Columbus Circle Investors added most to FMC in Q2 2017, an estimated $48.7M increase.
  • Columbus Circle Investors's biggest Q2 2017 reduction was Microsoft, cutting an estimated $69.7M.
  • Columbus Circle Investors fully exited Intuitive Surgical in Q2 2017, selling an estimated $92.1M.
  • Columbus Circle Investors's ten largest holdings make up 22% of its $6.05B portfolio in Q2 2017.
  • Columbus Circle Investors opened 64 new positions and closed 91 in Q2 2017.
  • Columbus Circle Investors's portfolio value fell 15% quarter-over-quarter to $6.05B.

Based on Columbus Circle Investors's 13F filing for Q2 2017, filed 4 Aug 2017.